Connect with us

Finance

GRAIL Reports Third Quarter 2025 Financial Results

Published

on

GRAIL Reports Third Quarter 2025 Financial Results

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million

Q3 Galleri Tests Sold Grew 39% Year-Over-Year to More Than 45,000

Galleri PMA Submission to FDA Now Anticipated in Q126

Cash Position of More Than $850 Million Includes Recently Completed Private Placement

MENLO PARK, Calif., Nov. 12, 2025 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter of 2025.

Advertisement

Total revenue in the third quarter grew 26% year-over-year to $36.2 million, and Galleri revenue grew 29% year-over-year to $32.8 million. U.S. Galleri revenue was $32.6 million, representing 28% growth year-over-year. Net loss for the quarter was $89.0 million. Gross loss was $13.7 million. Non-GAAP adjusted gross profit was $20.0 million, and non-GAAP adjusted EBITDA was $(71.7) million.1

“We remain very pleased by Galleri’s commercial uptake with 39% growth in Galleri test volume in the third quarter. Our teams continue to build awareness of Galleri among providers and patients, and recent data from our registrational PATHFINDER 2 study adds to the evidence base,” said Bob Ragusa, Chief Executive Officer at GRAIL. “We have also made key recent strides in opportunities beyond the U.S., led by our strategic collaboration with Samsung to bring Galleri to key Asian markets, as well as Galleri’s commercial introduction in Canada. Looking ahead, we anticipate completing our PMA submission for Galleri to the FDA in the first quarter of 2026.”

For the three months ended September 30, 2025, as compared to the three months ended September 30, 2024, GRAIL reported:

  • Revenue: Total revenue, comprised of screening and development services revenue, was $36.2 million, an increase of $7.5 million or 26%.
  • Net loss: Net loss was $89.0 million, an improvement of $36.7 million or 29%.
  • Gross loss: Gross loss was $13.7 million, an improvement of $8.5 million or 38%.
  • Adjusted gross profit1: Adjusted gross profit was $20.0 million, an increase of $8.2 million or 69%.
  • Adjusted EBITDA1: Adjusted EBITDA was $(71.7) million, an improvement of $36.5 million or 34%.
  • Cash position: Cash, cash equivalents, restricted cash and short-term marketable securities totaled $547.1 million as of September 30, 2025.

Recent business highlights include:

  • Positive results from PATHFINDER 2 and SYMPLIFY studies add to the evidence base for the effectiveness of multi-cancer early detection.
  • Positive detailed performance and safety results from the pre-specified analysis of the first approximately 25,000 participants in the registrational PATHFINDER 2 study were presented at the European Society of Medical Oncology (“ESMO”) Congress 2025 in October:
    • Adding Galleri to recommended screenings for breast, cervical, colorectal, and lung cancers (USPSTF A and B recommendations) led to a more than seven-fold increase in the number of cancers found within a year
    • Galleri detected approximately three times as many cancers when added to standard-of-care screening for breast, cervical, colorectal, lung, and prostate cancers (USPSTF A, B, and C recommendations)
    • Approximately three-quarters of the cancers detected by Galleri do not have standard of care screening options
    • More than half of the new cancers detected by Galleri were stage 1 or 2 and more than two-thirds were detected at stages 1-3
    • Galleri positive predictive value (“PPV”), or the likelihood of receiving a cancer diagnosis following a positive test result, was 61.6%
    • Specificity was 99.6%, translating to a false positive rate of 0.4%
    • Cancer signal of origin accuracy was 92%, leading to efficient diagnostic workups
    • Diagnostic resolution took a median of 46 days, and only 0.6% of all participants had an invasive procedure and invasive procedures were two times more common in participants with cancer than in those without
    • No serious, study-related adverse events were reported
  • Positive long-term results from an extended registry follow-up of the SYMPLIFY study with the University of Oxford were presented at the Early Detection of Cancer Conference (“EDCC”) in October. A previous primary analysis, published in The Lancet Oncology, followed participants until diagnostic resolution or up to nine months and demonstrated Galleri’s PPV was 75.5%. Patients reported to have a false positive Galleri result were followed for 24 months in national cancer registries for England and Wales.
    • The updated analysis presented at EDCC showed that approximately one-third of participants initially believed to have a false positive result were later diagnosed with cancer during the subsequent follow up period
    • This reduction in false positives resulted in an increase of Galleri’s PPV in this symptomatic population to 84.2%
  • Announced a collaboration with Medcan, a global leader in proactive health and wellness services, to provide access to the Galleri test at Medcan’s clinics. Additionally, Manulife Canada announced it now offers access to Galleri, in partnership with Medcan, to eligible life insurance customers through its innovative Manulife Vitality program.
  • Announced a strategic collaboration with Samsung in October to bring the Galleri test to key Asian markets. Subject to execution of definitive agreements, the parties will work as exclusive partners to commercialize Galleri in Korea, and possibly other key Asian markets, including Japan and Singapore. In addition, the parties intend to explore potential additional strategic and operational collaborations. Samsung has also agreed to make an equity investment of $110 million in GRAIL, subject to closing conditions.
  • Completed a private placement of equity in October resulting in gross proceeds of approximately $325 million, before deducting placement agents’ fees and other expenses. Including proceeds from this transaction, GRAIL’s cash position of more than $850 million provides runway into 2030.




1 See “Non-GAAP Disclosure” and the associated reconciliations for important information about our use of non-GAAP measures.

Conference Call and Webcast
A webcast and conference call will be held today, Nov. 12, 2025, at 1:30 p.m. PT / 4:30 p.m. ET. Individuals interested in listening to the conference call may access it on the investor relations section of GRAIL’s website at investors.grail.com.

Advertisement

A replay of the webcast will be available on GRAIL’s website for 30 days.

GRAIL Analyst Day 2025 Tomorrow
GRAIL will host its Analyst Day 2025 tomorrow, Nov. 13, 2025, at the Company’s central laboratories in Research Triangle Park, North Carolina beginning at 8:00 a.m. PT / 11:00 a.m. ET.

The live webcast and recorded replay will be available at the investor relations section of GRAIL’s website at investors.grail.com and at https://grail-analyst-day-2025.open-exchange.net/registration.

About GRAIL
GRAIL, Inc. is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL’s common stock is listed under the ticker symbol “GRAL” on the NASDAQ Stock Exchange.

For more information, visit grail.com.

Advertisement

About Galleri®
The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique “fingerprint” of cancer, to help screen for some of the deadliest cancers that don’t have recommended screening today, such as pancreatic, esophageal, ovarian, liver, and others. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer, giving healthcare providers a roadmap of where to explore further. The Galleri test requires a prescription from a licensed healthcare provider and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, or cervical cancer screening. The Galleri test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older.

For more information, visit galleri.com.

Laboratory/Test Information
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the U.S. Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

Non-GAAP Disclosure
In addition to our financial results provided throughout this press release that are determined in accordance with U.S. generally accepted accounting principles (“GAAP”), this press release also includes financial measures that are not calculated in accordance with GAAP. Our non-GAAP financial disclosure includes Adjusted Gross Profit (Loss) and Adjusted EBITDA. We encourage investors to carefully consider our results under GAAP in conjunction with our supplemental non-GAAP information and the reconciliation between these presentations.

  • Adjusted Gross Profit (Loss) is a key performance measure that our management uses to assess our operational performance, as it represents the results of revenues and direct costs, which are key components of our operations. We believe that this non-GAAP financial measure is useful to investors and other interested parties in analyzing our financial performance because it reflects the gross profitability of our operations, and excludes the costs associated with our sales and marketing, product development, general and administrative activities, and depreciation and amortization, and the impact of our financing methods and income taxes.

    We calculate Adjusted Gross Profit (Loss) as gross profit (loss) (as defined below) adjusted to exclude amortization of intangible assets and stock-based compensation allocated to cost of revenue. Adjusted Gross Profit (Loss) should be viewed as a measure of operating performance that is a supplement to, and not a substitute for, operating income or loss from operations, net earnings or loss and other GAAP measures of income (loss) or profitability. The following table presents a reconciliation of gross loss, the most directly comparable financial measure calculated in accordance with GAAP, to Adjusted Gross Profit.

  • Adjusted EBITDA is a key performance measure that our management uses to assess our financial performance and is also used for internal planning and forecasting purposes. We believe that this non-GAAP financial measure is useful to investors and other interested parties in analyzing our financial performance because it provides a comparable overview of our operations across historical periods. In addition, we believe that providing Adjusted EBITDA, together with a reconciliation of net income (loss) to Adjusted EBITDA, helps investors make comparisons between our company and other companies that may have different capital structures, different tax rates, different operational and ownership histories, and/or different forms of employee compensation.

    Adjusted EBITDA is used by our management team as an additional measure of our performance for purposes of business decision-making, including managing expenditures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our financial results that may not be shown solely by period-to-period comparisons of net income (loss) or income (loss) from operations. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, and may not be directly comparable to similarly titled metrics used by other companies.

    We calculate Adjusted EBITDA as net income (loss) adjusted to exclude interest (income) expense, income tax expense (benefit), depreciation, impairment of goodwill and intangible assets, and amortization of intangible assets, which represent intangible assets resulting from pushdown accounting, legal and professional services fees related to Illumina’s acquisition of the Company in August 2021 (“the Acquisition”) and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and our divestment from Illumina, restructuring charges, and stock-based compensation. We believe that the items subject to these further adjustments are not indicative of our ongoing operations due to their nature, especially considering the impact of certain items as a result of the Acquisition.

    Advertisement

    Adjusted EBITDA should be viewed as a measure of operating performance that is a supplement to, and not a substitute for, operating income or loss from operations, net earnings or loss and other U.S. GAAP measures of income (loss). Additionally, it is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest and tax payments. Further, our definition of Adjusted EBITDA may differ from similarly titled measures used by other companies and therefore may not be comparable among companies. The following table presents a reconciliation of net loss, the most directly comparable financial measure calculated in accordance with U.S. GAAP, to Adjusted EBITDA on a consolidated basis.

Full reconciliation of these non-GAAP measures to the most comparable GAAP measures is set forth in tabular form below.

Forward-Looking Statements
This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “aim,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should,” “would,” or “will,” the negative of these terms, and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include expectations and projections of our future financial performance, future tests or products, patient awareness of our products, technology, clinical studies, safety results, regulatory compliance, potential market opportunity, anticipated growth strategies, restructuring costs, sufficiency of cash on hand to finance our business, cost savings, budgets and strategies, satisfaction of closing conditions and negotiation of definitive agreements in the Samsung collaboration, and growth and anticipated trends in our business.

These statements are only predictions based on our current expectations and projections about future events and trends. There are important factors that could cause our actual results, level of activity, performance, or achievements to differ materially and adversely from those expressed or implied by the forward-looking statements, including those factors and numerous associated risks discussed under the sections entitled “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2024 and in our Quarterly Reports on Form 10-Q for the periods ended March 31, 2025, June 30, 2025 and September 30, 2025. Moreover, we operate in a dynamic and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results, level of activity, performance, or achievements to differ materially and adversely from those contained in any forward-looking statements we may make.

Forward-looking statements relate to the future and, accordingly, are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Although we believe the expectations and projections expressed or implied by the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update any of these forward-looking statements after the date of this press release to conform our prior statements to actual results or revised expectations or to reflect new information or the occurrence of unanticipated events.

Advertisement

GRAIL, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(amounts in thousands, except share and per share data)



September 30,
2025

Advertisement

December 31,
2024

Assets




Current assets:




Cash and cash equivalents

$                  126,892

Advertisement

$                  214,234

Short-term marketable securities

413,238


549,236

Accounts receivable, net

Advertisement

16,282


20,312

Supplies

18,390


18,632

Advertisement

Prepaid expenses and other current assets

14,579


17,447

Total current assets

589,381

Advertisement

819,861

Property and equipment, net

56,180


69,061

Operating lease right-of-use assets

Advertisement

56,061


66,373

Restricted cash

6,974


3,349

Advertisement

Intangible assets, net

1,885,140


2,016,890

Other non-current assets

7,295

Advertisement

7,773

Total assets

$               2,601,031


$               2,983,307

Liabilities and stockholders’ equity

Advertisement



Current liabilities:




Accounts payable

$                      3,407


$                      4,844

Accrued liabilities

Advertisement

58,076


57,241

Operating lease liabilities, current portion

14,022


13,260

Advertisement

Other current liabilities

1,928


1,580

Total current liabilities

77,433

Advertisement

76,925

Operating lease liabilities, net of current portion

44,568


54,881

Deferred tax liability, net

Advertisement

236,265


345,860

Other non-current liabilities

2,802


2,236

Advertisement

Total liabilities

361,068


479,902

Preferred stock, par value of $0.001 per share; 50,000,000 shares
authorized, no shares issued and outstanding as of September 30,
2025 and December 31, 2024

Advertisement

Common stock $0.001 par value per share, 1,500,000,000 shares
authorized, 36,160,998 shares issued and outstanding as of
September 30, 2025, 33,893,409 shares issued and outstanding as of
December 31, 2024

36


34

Additional paid-in capital

Advertisement

12,349,976


12,305,250

Accumulated other comprehensive income

2,456


1,451

Advertisement

Accumulated deficit

(10,112,505)


(9,803,330)

Total stockholders’ equity

2,239,963

Advertisement

2,503,405

Total liabilities and stockholders’ equity

$               2,601,031


$               2,983,307

Advertisement

GRAIL, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

(amounts in thousands, except share and per share data)



Three Months Ended

Advertisement

Nine Months Ended


September 30,
2025


September 30,
2024


September 30,
2025


September 30,
2024

Advertisement

Revenue:








Screening revenue

$            32,807


$            25,374


$            96,319

Advertisement

$            77,076

Development services revenue

3,387


3,278


7,256

Advertisement

10,267

Total revenue

36,194


28,652


103,575

Advertisement

87,343

Costs and operating expenses:








Cost of screening revenue (exclusive of
     amortization of intangible assets)

15,910


15,970

Advertisement

52,379


45,481

Cost of development services revenue

544


1,442

Advertisement

2,216


3,499

Cost of revenue — amortization of intangible
     assets

33,473


33,473

Advertisement

100,417


100,417

Research and development

48,647


78,231

Advertisement

148,898


274,052

Sales and marketing

25,503


35,625

Advertisement

89,021


123,433

General and administrative

37,408


47,418

Advertisement

120,396


171,745

Goodwill and intangible assets impairment


Advertisement

28,000


1,420,936

Total costs and operating expenses

161,485


212,159

Advertisement

541,327


2,139,563

Loss from operations

(125,291)


(183,507)

Advertisement

(437,752)


(2,052,220)

Other income:








Interest income

6,107

Advertisement

11,661


20,695


17,367

Other income (expense), net

466

Advertisement

(561)


(929)


(514)

Total other income, net

6,573

Advertisement

11,100


19,766


16,853

Loss before income taxes

(118,718)

Advertisement

(172,407)


(417,986)


(2,035,367)

Benefit from income taxes

29,741

Advertisement

46,719


108,811


105,428

Net loss

$          (88,977)

Advertisement

$        (125,688)


$        (309,175)


$     (1,929,939)

Net loss per share — Basic and Diluted

$              (2.46)

Advertisement

$              (3.94)


$              (8.73)


$            (61.61)

Weighted-average shares of common stock
     used in computing net loss per share:

36,124,256

Advertisement

31,880,054


35,415,266


31,326,117

 

Advertisement

GRAIL, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

(amounts in thousands)



Three Months Ended

Advertisement

Nine Months Ended


September 30,
2025


September 30,
2024


September 30,
2025


September 30,
2024

Advertisement

Gross loss (1)

$          (13,733)


$          (22,233)


$      (51,437)


$      (62,054)

Advertisement

Amortization of intangible assets

33,473


33,473


100,417


100,417

Advertisement

Stock-based compensation

271


578


1,450


1,522

Advertisement

Adjusted Gross Profit

$            20,011


$            11,818


$        50,430


$        39,885

Advertisement






(1)

Gross loss is calculated as total revenue less cost of screening revenue (exclusive of amortization of intangible assets), cost of development services revenue and cost of revenue—amortization of intangible assets.

 

Advertisement

GRAIL, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

(amounts in thousands)



Three Months Ended

Advertisement

Nine Months Ended


September 30,
2025


September 30,
2024


September 30,
2025


September 30,
2024

Advertisement

Net loss

$          (88,977)


$        (125,688)


$        (309,175)


$     (1,929,939)

Advertisement

Adjusted to exclude the following:








Interest income

(6,107)


(11,661)


(20,695)

Advertisement

(17,367)

Benefit from income tax expense

(29,741)


(46,719)


(108,811)

Advertisement

(105,428)

Amortization of intangible assets (1)

34,583


34,583


103,750

Advertisement

103,750

Depreciation

4,399


4,647


13,686

Advertisement

14,865

Goodwill and intangible impairment (2)



28,000

Advertisement

1,420,936

Illumina/GRAIL merger & divestiture
     legal and professional services costs(3)


226


Advertisement

22,158

Stock-based compensation(4)

14,139


17,449


44,518

Advertisement

72,502

Restructuring(5)


19,007


(34)

Advertisement

19,007

Adjusted EBITDA

$          (71,704)


$        (108,156)


$        (248,761)

Advertisement

$        (399,516)







(1)

Represents amortization of intangible assets, including developed technology and trade names.

(2)

Advertisement

Reflects impairment of goodwill and intangible assets recognized as a result of the Acquisition.

(3)

Represents legal and professional services costs associated with the Acquisition and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and legal and professional services costs associated with the divestiture.

(4)

Represents all stock-based compensation recognized on our standalone financial statements for the periods presented.

Advertisement

(5)

Represents employee severance, benefits, payroll taxes, and other costs associated with the Restructuring Plan.

SOURCE GRAIL, Inc.

Advertisement

Finance

Chicago finance committee approves alternate budget proposal without mayor’s controversial head tax

Published

on

Chicago finance committee approves alternate budget proposal without mayor’s controversial head tax

CHICAGO (WLS) — A Chicago City Council committee approved an alternative budget plan brought by a group of alderpersons on Tuesday.

A group of alderpersons presented the plan, which more than half of city council members are currently supporting, during Tuesday’s Finance Committee meeting.

ABC7 Chicago is now streaming 24/7. Click here to watch

The substitute budget ordinance faced scrutiny from supporters of Mayor Brandon Johnson’s budget during the hearing, which lasted several hours.

The alternate budget group is looking to build support for their plan even as they put additional council meetings on the schedule, including meetings this weekend and on Christmas Eve.

The Finance Committee meeting revealed some new revenue options for the 2026 budget proposal and tweaked some others.

Advertisement

It includes raising the plastic shopping bag tax from $0.10 to $0.15, and a pilot program to put advertising on bridge houses as well as light poles.

RELATED | Chicago City Council revises alternative budget proposal, mayor defends head tax as deadline looms

It officially gets rid of the corporate head tax, which has been a major source of contention since Johnson first presented his budget plan. The mayor and his allies are insisting that corporations pay more.

“What you have here is balancing the budget with fines and fees and taking out the corporate head tax. I want to hear your rationale to do that,” said 25th Ward Ald. Byron Sigcho-Lopez.

“Our proposal, in terms of new revenues, impacts businesses at 84% and individuals at 16%. I want everybody to take a look at this for a minute,” said Budget Committee Vice Chair Ald. Nicole Lee.

Advertisement

The alternative budget group says this plan is 98% in line with Johnson’s. Still, some of his allies were frustrated at not seeing the numbers sooner.

READ MORE | Chicago budget discussions reach stalemate, raising possibility of 1st-ever city government shutdown

“This is our first time reviewing this. This is incredibly disrespectful,” said 35th Ward Ald. Anthony Quezada.

There were also questions about the alternate plan to sell off outstanding debt to raise nearly $90 million. The city comptroller cautioned against it.

“I would say is that I would not. I would not rely on $89 million in this budget. This has never been done by any state,” said Chicago Comptroller Michael Belsky.

Advertisement

But supporters are defending this plan as worthy of consideration calling projections conservative and balanced.

“The group that’s worked on this has spent hundreds of hours bringing in the majority of the city council to talk about this,” said 19th Ward Ald. Matt O’Shea. “We relied on the advice and counsel of budgetary experts.”

The alternative budget plan passed out of finance committee 22-13. Its next stop is the Budget Committee on Wednesday.

It is clear that this breakaway group is flexing its muscle. What’s not clear is what the mayor’s next move will be.

But we now have city council meetings planned for Thursday, Friday, Saturday, and then, Tuesday and Wednesday of next week.

Advertisement

Johnson issued a statement on Tuesday evening, saying, “As the leaders of the Alternative Group made clear throughout their presentation, the Secret Budget that passed out of the Finance Committee this afternoon is substantially similar to the proposal we introduced more than two months ago.

At our insistence, the Alternative Group agreed to restore the cuts they made to youth employment, and they removed the proposal to double the garbage tax. They have finally conceded to some degree, the point that I have made from the beginning: that corporations must pay their fair share in order to protect Chicagoans at this moment.

Unfortunately, at the behest of certain corporate interests, they chose to replace a tax on the largest corporations with $90M+ in “enhanced debt collections” on everyday Chicagoans. This seems to be in direct contradiction with their expressed desires to shift the financial burden away from working people.

Not only is this proposal immoral, it is simply not feasible. There is no way to sell off Chicagoans’ debts that would yield that amount of revenue. If passed as is, this proposal would likely result in a significant midyear budget shortfall and leave Chicagoans vulnerable to deep cuts to city services.

We will spend the next few days with our budget, finance, legal, and policy teams reviewing these proposals. Chicago cannot afford a government shutdown when we are making so much progress growing our economy and reducing violent crime to historic lows.

Advertisement

Tomorrow, the Budget Committee will review their proposal publicly so that Chicagoans can understand exactly what is in this Secret Budget.”

Copyright © 2025 WLS-TV. All Rights Reserved.

Continue Reading

Finance

The Boring Revolution: How Trust and Compliance Are Taking Over Digital Finance – FinTech Weekly

Published

on

The Boring Revolution: How Trust and Compliance Are Taking Over Digital Finance – FinTech Weekly

In digital finance, trust and compliance are becoming the true drivers of scale. An op-ed by Brickken CEO Edwin Mata examines why regulation is shaping the sector’s next phase.

Edwin Mata is CEO & Co-Founder of Brickken.

 


 

Discover top fintech news and events!

Advertisement

Subscribe to FinTech Weekly’s newsletter

Read by executives at JP Morgan, Coinbase, Blackrock, Klarna and more

 


In digital finance, we love noise. New apps, tokens, and “disruptive” models get all the airtime. Yet, the real inflection point is unfolding in the most unglamorous corner of the industry: compliance, governance, and record-keeping.

Regulation is not the backdrop to innovation. It is the mechanism through which the sector becomes investable, scalable and credible. Today’s inflection point is defined not by a new consumer product but by whether digital assets can meet the governance expectations that global finance takes for granted.

Advertisement

 

Regulation as the Moment of Maturity

Traditional finance learned this a long time ago. Modern capital markets only became investable at scale after securities laws in the 1930s forced transparency, continuous disclosure, and enforcement, restoring confidence after catastrophic failures. The US Securities Exchange Act of 1934 didn’t kill markets; it gave them the legal scaffolding to grow into the backbone of global savings.

Crypto and digital assets are now entering a similar “boringly serious” phase. In the EU, the Markets in Crypto-Assets Regulation, or MiCA, is designed to give legal clarity to crypto-asset issuers and service providers. For institutional compliance teams, that kind of predictability is far more important than whichever buzzword happens to dominate a conference stage.

The impact on capital flows is already visible: 83% of institutional investors plan to increase allocations to digital assets with regulatory clarity as a key driver of that enthusiasm. Clear rules don’t strangle innovation, they compress uncertainty and lower the risk premium that has kept cautious money on the sidelines.

 

Advertisement

The Boring Revolution Behind Institutional Capital

That’s why the real story in digital finance is a “boring revolution.” The work that actually matters now is the industrialisation of KYC and KYB, AML monitoring, standardized reporting, on-chain and off-chain reconciliation, governance workflows, and provable rights attached to digital instruments. The industry still loves to obsess over the next shiny app, but the real bottleneck is whether institutions can trust the rails beneath the interface.

RegTech has quietly reframed compliance tooling as an edge rather than a punishment. Technology-driven compliance improves risk assessment, fraud detection, and overall competitiveness because it lets institutions scale digital finance without losing sight of their exposure. That is where the durable upside sits, in making digital assets behave like a serious asset class, not a speculative game with good branding.

From the vantage point of building tokenization infrastructure, the pattern is consistent. When institutions evaluate real-world-asset tokenization, they don’t begin by asking which chain you use or how “decentralized” it is. Their focus is not the chain. It is whether ownership, entitlements, corporate actions and governance can be evidenced, enforced and audited in ways that align with securities law and accounting standards. If those foundations are sound, the rest of the architecture becomes negotiable.

You can see the same shift in where venture money is going. Over 70% of digital asset investment now targets institutional and infrastructure-focused platforms, up from just 27% a decade ago; the funding narrative has pivoted away from consumer speculation toward institutional plumbing. 

That is not a romantic story, but it is the kind that tends to survive more than one market cycle.

Advertisement

 

From Flashy Apps to Trustworthy Systems

Banks and large asset managers are adjusting their priorities accordingly. Governance, risk management, and compliance modernisation are stressed as core investment themes, especially as new digital-asset rules and prudential standards come into force. Digital finance is being pulled into the centre of regulated balance sheets and internal control frameworks.

At the same time, some institutions now describe digital assets, including tokenized bonds and money-market funds, as a “mainstream subject” for their clients. We explicitly link the shift from fringe to mainstream to better regulatory frameworks and institutional-grade infrastructure rather than retail hype. The catalyst is not design; it is the underlying certainty that these instruments carry governance, accounting treatment and supervisory oversight consistent with established financial products.

This is the narrative inversion digital finance still struggles with. For a decade, the space behaved as if UX, community and tokenomics could overpower everything else. That era produced experimentation, but also a long tail of ungoverned projects that institutional capital simply cannot touch.

If digital finance wants to sit alongside public equities, investment-grade debt and regulated funds, the front end has to be the last question. What matters is whether the system can prove who owns what, under which rules, and with what recourse when things go wrong. That’s the baseline requirement for anyone managing real risk.

Advertisement

 

Compliance as Product, Not Overhead

The opportunity for fintech founders now is to treat compliance engineering, data governance and risk architecture as core product. The firms that take regulatory expectations seriously, encode them into workflows, and expose them as reliable platforms will become the quiet chokepoints of the next cycle. Regulated entities won’t integrate ten different “innovative” front ends if each one creates a new audit headache; they will integrate the boring rails that make their auditors and supervisors more comfortable, not less.

Collaboration with regulators is becoming central to this shift. Around the world, supervisory authorities are establishing innovation pathways, industry working groups and controlled testing environments that allow technical design and regulatory expectations to evolve together. This model may disappoint purists who prefer unbounded experimentation, but it is the only credible way to align programmable financial systems with the governance, risk and reporting obligations of real-world finance.

The irony is that the least glamorous corner of digital finance is where the most durable value will be created. The “boring revolution” is the recognition that trust, compliance and governance are not obstacles to innovation but the substrate on which the next generation of financial systems will quietly compound.

 

Advertisement
Continue Reading

Finance

Santa Barbara Unified School Board Shakes Up Finance Committee Amid Annual Budget Report

Published

on

Santa Barbara Unified School Board Shakes Up Finance Committee Amid Annual Budget Report

As the Santa Barbara Unified school board faces a projected $20 million deficit and declining reserves, trustees voted unanimously Thursday night to change who leads the district’s Finance Committee — removing community member Todd Voigt in favor of future boardmember leadership.

The move — approved in Resolution 2024-25-32A — immediately drew criticism from parents, primarily on the Facebook page S.B. Parent Leadership Action Network (S.B. PLAN), who accused the board of consolidating power just as the district’s fiscal outlook grows increasingly precarious.

“This is a power grab,” said Michele Voigt, wife of Todd Voigt and a San Marcos parent who spoke during public comment. “We are at a point of serious financial concern, and the board is reducing independent oversight.”

Voigt urged the board to view the First Interim Budget Report as more than numbers on a slide. “I’m asking you tonight to look at this first interim not as a technical report, but a test of your governance and your duty to the community you represent,” she said. “Your own projections point to reserves falling below the state minimum and trending toward zero within a few years. And no one will be able to say that they didn’t see it coming.”

Despite Voigt’s comments, the district’s interim financial report told a more nuanced story. The district’s chief business official, Conrad Tedeschi, iterated different figures, figures that were part of the long-term financial plan approved by the board. Overall the numbers were not a surprise, emphasizing that the district is not in crisis and remains above the state-mandated 3 percent minimum reserve level.

Advertisement

According to Tedeschi, there are improved revenue projections and a growing deficit. Total revenue for 2024-25 increased to $244 million, up from the adopted budget, driven by higher-than-expected one-time grants, including a major boost to the Expanded Learning Opportunity Program, which rose from a projected $3 million to $5.2 million after the state updated its formula. However, expenditures also climbed, pushing the projected deficit from $15 million to $20 million. Tedeschi said the increase reflects rising labor costs following the district’s recent wage settlement with teachers. Salaries and benefits now account for 81 percent of all district spending. 

Despite the shortfall, Tedeschi emphasized that reserves remain above target: currently at 8.52 percent, compared to the board’s adopted budget of 8.92 percent and well above the state-required 3 percent minimum. Multi-year projections show that with planned reductions, the deficit could shrink to $6.7 million by 2027-28, provided the district makes at least $6 million in cuts over the next two years to maintain a minimum 5 percent reserve. “That’s not a satisfactory level for a basic aid district,” Tedeschi said, “but staying above 5 percent is the minimum needed to keep our budget certified.”

Still, there was ongoing tension over who chairs the Finance Committee — centering on concerns about transparency and legal compliance. The board’s newly passed resolution requires that only elected trustees can serve as committee chair, replacing community member Todd Voigt with a boardmember moving forward.

At the heart of the move is compliance with the Brown Act, California’s open-meeting law that governs transparency in public agencies. Under the law, committees subject to the Brown Act must have properly agendized items for any votes or actions to be legal and binding. Board President William Banning said the Finance Committee had previously taken action on items not properly listed on agendas, potentially violating the law and opening the district to liability. 

“These amendments reinforce that commitment [to compliance] and position the Finance Committee to continue its work in a way that is focused, lawful, collaborative, and ultimately highly valuable to the board and the community we serve,” Banning said.

Advertisement

The amended resolution changes Finance Committee bylaws to require that only a boardmember may serve as chair, ending Voigt’s tenure. It also outlines procedures for member removal and reaffirms the committee’s advisory-only role.

“I am the Chair of the Finance Committee, maybe for 15 more minutes,” said Todd Voigt during public comment. “I agreed to serve because I care deeply about this community and its future. I’m a volunteer with no political ambitions. My sole purpose is to provide sound advice and expertise for the benefit of our schools.”

Voigt called the resolution a “serious mistake” and warned that removing the independent chair would erode the very trust the district had been trying to rebuild. “If the board controls both the committee and its leadership, that independence disappears,” he said.

He also made a pointed recommendation to the board. “Should this passage occur … I strongly urge the board to select Boardmember [Celeste] Kafri as the chairperson. She has consistently demonstrated a commitment to addressing the district’s financial challenges,” Voigt said. “By contrast… Boardmember Banning opposed a committee goal I proposed to reduce the deficit. Leadership that does not prioritize deficit reduction is unacceptable.”

Board President William Banning, who was formally elected to the role earlier in the evening, defended the resolution and its timing.

Advertisement

“This is a normal part of building effective governance structures,” he said. “The resolution … strengthens Brown Act compliance … clarifies the committee’s strictly advisory role … and ensures that meetings are presided over by a trustee trained in Open Meeting Law and accountable to the public.”

Banning said that while the original intent was to demonstrate openness by appointing a community chair, it had created confusion around agenda-setting and governance boundaries. “That pattern typically follows the line of … a community member is chair in an attempt to demonstrate openness and shared leadership … and then in early meeting experiences, there is agenda-setting confusion, there’s boundary drift, and difficulties with Brown Act procedures.”

Boardmember Kafri pushed back on parts of the resolution, questioning why the committee chair needed to be replaced at all. “Why is it that we need to replace the committee head … because of a misunderstanding about the Brown Act when most of the committee members have never been on a Brown Act committee before?” she asked. “Could an orientation and a better understanding … prevent future Brown Act violations?”

That prompted clarification from Banning: “It is not only common, but standard practice throughout the state of California … that the committee chair be one of the appointed board representatives.”

Boardmember Gabe Escobedo supported Kafri’s interest in making the committee more effective, but reminded the board to stay focused. “More of what Ms. Kafri is talking about is like the mechanics, and I trust that Mr. Tedeschi will be responsive to the needs of the group and be able to present the information in a way that is going to be digestible,” he said. “What I would hope is that we can focus more on just the mechanics of what’s in the resolution — the words.”

Advertisement

The resolution passed unanimously, but not without raising questions about trust, power, and what transparency means when community expertise is asked to sit down.

As Escobedo noted: “We have the fiduciary responsibility…. It only makes sense to direct the work of the advisory committee to aid us in making those really difficult decisions.”

Advertisement

Advertisement
Continue Reading

Trending